TransMedics Group Inc
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic con… Read more
TransMedics Group Inc (TMDX) - Total Assets
Latest total assets as of December 2025: $1.07 Billion USD
Based on the latest financial reports, TransMedics Group Inc (TMDX) holds total assets worth $1.07 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
TransMedics Group Inc - Total Assets Trend (2006–2025)
This chart illustrates how TransMedics Group Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
TransMedics Group Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
TransMedics Group Inc's total assets of $1.07 Billion consist of 59.7% current assets and 40.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 45.7% |
| Accounts Receivable | $84.28 Million | 7.9% |
| Inventory | $48.88 Million | 4.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.95 Million | 0.2% |
| Goodwill | $11.55 Million | 1.1% |
Asset Composition Trend (2006–2025)
This chart illustrates how TransMedics Group Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: TransMedics Group Inc's current assets represent 59.7% of total assets in 2025, a decrease from 85.7% in 2006.
- Cash Position: Cash and equivalents constituted 45.7% of total assets in 2025, down from 60.5% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 7.9% of total assets.
TransMedics Group Inc Competitors by Total Assets
Key competitors of TransMedics Group Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
TransMedics Group Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - TransMedics Group Inc generates 0.57x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, TransMedics Group Inc generates $ 17.81 in net profit.
TransMedics Group Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.14 | 8.30 | 11.95 |
| Quick Ratio | 6.59 | 7.52 | 10.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $548.48 Million | $ 437.30 Million | $ 128.79 Million |
TransMedics Group Inc - Advanced Valuation Insights
This section examines the relationship between TransMedics Group Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.40 |
| Latest Market Cap to Assets Ratio | 3.51 |
| Asset Growth Rate (YoY) | 32.9% |
| Total Assets | $1.07 Billion |
| Market Capitalization | $3.75 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values TransMedics Group Inc's assets at a significant premium ( 3.51x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: TransMedics Group Inc's assets grew by 32.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for TransMedics Group Inc (2006–2025)
The table below shows the annual total assets of TransMedics Group Inc from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $1.07 Billion | +32.87% |
| 2024-12-31 | $804.08 Million | +13.88% |
| 2023-12-31 | $706.05 Million | +154.76% |
| 2022-12-31 | $277.15 Million | +105.46% |
| 2021-12-31 | $134.89 Million | -11.27% |
| 2020-12-31 | $152.03 Million | +44.38% |
| 2019-12-31 | $105.30 Million | +149.78% |
| 2018-12-31 | $42.16 Million | +13.93% |
| 2017-12-31 | $37.00 Million | -36.32% |
| 2016-12-31 | $58.10 Million | +289.86% |
| 2006-12-31 | $14.90 Million | -- |